Z25-12115-05994
2 vaccinations
5 coded responses
20 check-ins
4 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 180 / PA
- Registered
- 2021-12-29
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-12-29
Registered in v-safe
-
2021-12-29
Dose 1 — Pfizer-BioNTech
- 2021-12-29
-
2021-12-30
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
-
2021-12-31
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2022-01-01
- 2022-01-03
- 2022-01-04
-
2022-01-05
Survey response — day 7, dose 1MedDRA: Decreased appetite — Feeling: GoodFree text: Slight loss of appetite (possibly pregnancy related)MedDRA releases: 2024-11 · check-in free text available
- 2022-01-12
- 2022-01-19
-
2022-01-21
Dose 2 — Pfizer-BioNTech
-
2022-01-26
Survey response — days 1–6 daily, dose 2MedDRA: Adverse reaction, Pregnancy — Feeling: GoodFree text: All symptoms I've felt have been related to pregnancy. Just gave birth at 39w.MedDRA releases: 2024-11 · check-in free text available
- 2022-01-27
-
2022-01-30
Survey response — day 7, dose 2MedDRA: Caesarean section, Insomnia, Procedural pain — Feeling: GoodFree text: Any pain that I have is likely due to the c-section I had and the lack of sleep due to having a newbornMedDRA releases: 2024-11 · check-in free text available
- 2022-02-04
- 2022-02-11
- 2022-02-18
- 2022-02-25
- 2022-03-04
- 2022-04-22
-
2022-07-22
Survey response — 6 months, dose 2MedDRA: COVID-19, Pre-existing disease, Tinnitus — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: COVID 19 made my preexisting tinnitus worse.MedDRA releases: 2024-11 · check-in free text available
-
2023-01-21
Survey response — 12 months, dose 2MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-12-29 | Pfizer-BioNTech | No |
| 2 | 2022-01-21 | Pfizer-BioNTech | No |
Free text
Release 10 — day 7, dose 1
Systemic reaction (other): Slight loss of appetite (possibly pregnancy related)
Release 11 — days 1–6 daily, dose 2
Systemic reaction (other): All symptoms I've felt have been related to pregnancy. Just gave birth at 39w.
Release 11 — day 7, dose 2
Systemic reaction (other): Any pain that I have is likely due to the c-section I had and the lack of sleep due to having a newborn
Release 12 — 6 months, dose 2
Symptoms: COVID 19 made my preexisting tinnitus worse.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Tinnitus | · | · | ✓ |
| SRO | Adverse reaction | · | · | ✓ |
| SRO | Caesarean section | · | · | ✓ |
| SRO | Decreased appetite | · | · | ✓ |
| SRO | Insomnia | · | · | ✓ |
| SRO | Pregnancy | · | · | ✓ |
| SRO | Procedural pain | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release